From: The Heartland Institute
Comment by The American Vaping Association on IQOS Modified Risk Tobacco Product Application
September 1, 2017
Scott Gottlieb, M.D.
Commissioner Division of Dockets Management (HFA-305)
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, MD 20852
Re: Docket No. FDA-2017-D-3001-0002, Modified Risk Tobacco Product Applications: Applications for iQOS System With Marlboro Heatsticks, iQOS System With Marlboro Smooth Menthol Heatsticks, and iQOS System With Marlboro Fresh Menthol Heatsticks Submitted by Philip Morris Products S.A.; Availability
Dear Dr. Gottlieb,
The American Vaping Association (AVA) is pleased to submit our comments regarding the modified risk tobacco product applications (MRTP) for iQOS and its associated varieties of Marlboro Heatsticks presently pending before the FDA. The AVA is a nonprofit organization that advocates for regulatory and legislative policies that recognize the harm reduction benefits of vapor products and other reduced-risk alternatives to combustible cigarettes. As strong believers in the possibility of the United States attaining a ‘smoke-free’ future with technology, innovation, and a recognition of informed human choice, we strongly recommended that the FDA approve these MRTP applications.